MOTS-c 10mg

THIS PRODUCT IS INTEDED AS A RESEARCH CHEMICAL ONLY.
This designation allows the use of research chemicals strictly in vitro for testing and laboratory experimentation only. All products information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professional. This product is not a drug, food or cosmetic and may not be misbranded, misused or mislabled as a drug food or cosmetic.

MOTS-c, being a mitochondrial-derived peptide composed of sixteen amino acids, stands as a matter of considerable consequence to those engaged in the study of cellular metabolism. It is a truth acknowledged amongst those versed in biochemistry that this molecule, synthesized within the mitochondrial compartments, occupies itself with the regulation of cellular energy through pathways of the utmost delicacy and precision. The peptide conducts itself with notable propriety, translocating to the nucleus where it exerts influence over the expression of genes pertaining to mitochondrial biogenesis and metabolic restoration—a function of particular import during periods of metabolic distress. Natural philosophy has revealed that MOTS-c possesses the capacity to enhance exercise-induced metabolic adaptation, ameliorate the disposition toward corpulence, restore that most desirable faculty of insulin sensitivity, improve the mitochondrial constitution of both cardiac and skeletal muscle, and address those afflictions of metabolic disorder and age-associated decline which trouble the human constitution. The molecule conducts itself, in short, as an agent of considerable utility in the scientific investigation of metabolic regulation.

1. MOTS-c Overview

It is a truth universally acknowledged that a peptide in possession of mitochondrial origin must be in want of rigorous investigation. MOTS-c—that is to say, Mitochondrial ORF of the 12S rRNA Type-C—presents itself as a peptide of sixteen amino acids, most handsomely encoded within the mitochondrial 12S rRNA gene. This substance possesses the character of a metabolic signaling molecule, one which demonstrates considerable propriety in its deportment by translocating to the cell nucleus during periods of metabolic stress, thereby regulating nuclear gene expression with the precision one might expect of an accomplished governess maintaining household order.

The researchers who engage with MOTS-c find themselves well occupied in the investigation of pathways pertaining to metabolic sensing, mitochondrial biogenesis, redox equilibrium, and those most admirable adaptive cellular responses—all conducted, it should be noted, within controlled laboratory environments befitting such genteel inquiry.

MOTS-c claims the distinction of being classified as a mitochondrial hormone, or mitokine, a designation most flattering to its character. Its detection across multiple tissues and throughout the circulating plasma attests to both local and systemic signaling capacity—much as a well-connected family maintains correspondence across distant counties. Particularly noteworthy is the observation that endogenous MOTS-c expression declines precipitously with advancing age, rendering it an object of considerable interest to those researchers devoted to the study of age-related metabolic degeneration and the mechanisms through which longevity itself might be preserved.

2. MOTS-c Structure

The structure of MOTS-c, though modest in its sixteen-residue composition, displays a most commendable architectural elegance:

Amino Acid Sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg

One-Letter Code: MRWQEMGYIFYPRKLR

Molecular Formula: C₁₀₁H₁₅₂N₂₈O₂₂S₂

Molecular Weight: 2174.64 g/mol

One must observe, with some circumspection, that the peptide's constitution includes methionine and tryptophan residues—components of somewhat delicate sensibility, prone to oxidation when subjected to improper conditions. The conscientious investigator would therefore be well advised to employ degassing techniques and exercise appropriate handling practices, thereby preserving the peptide's integrity throughout the course of in-vitro examination.

3. MOTS-c Research

3.1 Muscle Metabolism

The investigation of MOTS-c's relationship with skeletal muscle tissues has yielded findings of considerable interest. The peptide directs its efforts toward the enhancement of glucose transporter expression through AMPK pathway activation—an action most remarkable for its independence from conventional insulin signaling, thus presenting an alternative course of glucose uptake when the ordinary pathways have, so to speak, taken their leave.

In models of advanced age, MOTS-c treatment has demonstrated the commendable capacity to restore muscle glucose uptake to levels observed in younger specimens, an achievement suggesting potential applications in the investigation of age-related insulin resistance and the metabolic decline that so often accompanies the later years of life. The peptide further exerts its influence upon muscle cell growth, mitochondrial density, and the systemic energy balance through modulation of catabolic pathways engaged with glucose utilization and fatty acid oxidation—a most productive sphere of activity for the laboratory naturalist.

3.2 Fat Metabolism

The studies conducted upon laboratory models reveal that MOTS-c exercises considerable influence over adipose tissue metabolism, promoting the activation of brown fat with the same beneficial determination one might wish upon a sluggish country estate. It simultaneously acts to reduce the accumulation of white adipose tissue—an outcome achieved through AMPK pathway activation and inhibition of de novo purine biosynthesis, leading to elevated AICAR levels most gratifying to observe.

This cascade of molecular events may enhance fatty acid beta-oxidation whilst simultaneously reducing lipogenesis, thereby promoting lipolysis and metabolic homeostasis. The mechanism appears to operate through the regulation of nuclear gene expression, thereby shifting the metabolic priorities maintained within cells with an economy of means that would have met with Mr. Bennet's approval. The enhanced energy dissipation and heat production through uncoupling protein activity are phenomena of particular note to the discerning investigator.

3.3 Insulin Sensitivity

MOTS-c has distinguished itself in preclinical models through its capacity to improve whole-body insulin sensitivity with most gratifying consistency. Hyperinsulinemic-euglycemic clamp studies have documented approximately thirty percent increases in exogenous glucose infusion rates following short-term treatment—a numerical accomplishment not to be dismissed. The peptide prevents the hyperinsulinemia induced by high-fat dietary regimens and preserves glucose homeostasis with admirable reliability.

The effects upon insulin signaling occur through AMPK-dependent mechanisms and may involve the regulation of nuclear gene expression, thereby offering researchers an instrument of considerable utility for the examination of mitochondrial-nuclear cross-talk in the development of metabolic dysfunction.

3.4 Osteoporosis

Laboratory evidence of considerable standing suggests that MOTS-c promotes osteogenic differentiation of bone marrow mesenchymal stem cells via the TGF-β/Smad signaling pathway—a mechanism of such elegance as to merit careful study. The peptide demonstrates the capacity to upregulate genes associated with osteogenesis (ALP, Bglap, Runx2) and enhances type I collagen synthesis by osteoblasts with commendable vigor.

In preclinical models, MOTS-c has proven instrumental in preventing the bone loss induced by ovariectomy, achieving this through the inhibition of osteoclast formation by means of AMPK activation and modulation of the RANKL pathway. Such findings position MOTS-c as a most worthwhile subject for investigation into hormonal influences upon bone metabolism—a domain of inquiry combining both scientific rigor and considerable practical import.

3.5 Longevity

The expression of MOTS-c exhibits patterns most decidedly age-dependent, with declining levels corresponding in remarkable fashion to age-related metabolic decline. It should be noted that genetic variation, particularly that designated the K14Q polymorphism, alters the peptide's structure and activity in ways that merit serious investigation. Reduced-function variants have been associated with increased type 2 diabetes risk in certain populations—a correlation of no small significance.

The structural modification termed glutamate-to-lysine substitution at position 14 may influence functional properties and the processes through which cells themselves age—matters of profound consequence to any researcher devoted to understanding the mechanisms of temporality itself. The peptide's potential interaction with NAD+-dependent pathways and sirtuins, coupled with its demonstrated role in maintaining cellular homeostasis, positions MOTS-c as a most relevant molecular target for investigations into longevity and what modern researchers term "healthspan"—that extension of vigorous years which all sensible persons must regard with favor.

3.6 Heart Health

MOTS-c demonstrates applications of considerable promise within the domain of cardiovascular research, operating through mechanisms encompassing endothelial function, the inhibition of vascular calcification, and myocardial remodeling—all matters of the utmost consequence to those who regard cardiac integrity as a prerequisite for general well-being.

In studies wherein exercise training was combined with the administration of exogenous MOTS-c, the peptide exhibited the most gratifying capacity to enhance myocardial structural and functional parameters—including stroke work, cardiac output, and ejection fraction. This achievement suggests that the peptide may protect endothelial cells through AMPK activation and the modulation of inflammatory pathways, reducing the expression of pro-inflammatory cytokines and adhesion molecules whilst simultaneously supporting nitric oxide-dependent vasodilation.

Furthermore, MOTS-c treatment has demonstrated considerable capacity to reduce vascular calcification and improve blood pressure profiles in preclinical models—findings of evident significance to any investigator engaged in the examination of cardiovascular homeostasis.

Feature Bullets

• A sixteen-amino-acid mitochondrial-derived peptide of distinguished origin, encoded by the mitochondrial 12S rRNA gene; substantiated by an extensive body of peer-reviewed research conducted by serious investigators
• Presented in lyophilized powder format, ensuring long-term stability most gratifying to any researcher of prudent habit, with straightforward storage requirements at refrigeration or freezer temperatures
• A formulation of high purity (in excess of ninety-nine percent), manufactured through validated peptide synthesis techniques ensuring consistent lot-to-lot quality and the reliable laboratory results upon which serious inquiry depends
• Most particularly suited to research investigating AMPK signaling mechanisms, mitochondrial biogenesis, and the maintenance of cellular energy homeostasis—pathways of considerable interest to the scientifically minded
• Reconstitutes with admirable facility in bacteriostatic water, presenting no unusual complications, and proves compatible with the standard laboratory protocols and standard operating procedures one customarily maintains
• Demonstrates stability of uncommon duration following reconstitution—upwards of thirty days at refrigerated temperatures—thereby permitting the execution of multi-week experimental timelines and the conduct of serial testing procedures
• Applicable across multiple domains of investigation, encompassing the study of metabolism, aging processes, cardiovascular physiology, bone biology, and the various manifestations of mitochondrial dysfunction in controlled models

Technical Specifications Table

What the Researcher Should Know

For rigorous investigation of mitochondrial signaling and metabolic adaptation, MOTS-c 10 mg offers a research substrate of established utility.

• Purity: Greater than 98 percent, confirmed by high-performance liquid chromatography
• Molecular Weight: 2,174.64 grams per mole, verified through mass spectrometry
• Classification: A mitochondrial-derived peptide capable of nuclear translocation

Disclaimer: For research and laboratory use only. Users must comply with all applicable regulations and institutional policies.